Literature

Leading Radiation Oncologist Dr. Steven E. Finkelstein Joins Associated Medical Professionals of NY, an Affiliate of U.S. Urology Partners

Retrieved on: 
вторник, апреля 30, 2024
Medical Supplies, Biotechnology, Practice Management, Managed Care, Health, General Health, Radiology, Oncology, Medical Devices, Hospitals, Clinical Trials, Corporation, Micron Technology, University, Bangladesh Technical Education Board, Kidney, Hospital, Clinical research, Breast, National Cancer Institute, NMS, Literature, CARE, Prostate cancer, Radiation therapy, Patient, National Institutes of Health, Medicine, Physician, Lung, Radiation, Cancer, Medical imaging

Associated Medical Professionals of NY spans 18 locations in Central New York, including nine offices and nine hospitals.

Key Points: 
  • Associated Medical Professionals of NY spans 18 locations in Central New York, including nine offices and nine hospitals.
  • Radiation Oncology is the region’s leading provider of comprehensive cancer care services, providing the most advanced, effective treatments available for urological and other types of cancers.
  • Steven Finkelstein’s extensive experience in radiation oncology care and his leadership in the medical field will be a tremendous asset to U.S. Urology Partners, Associated Medical Professionals of NY and most importantly to individuals receiving cancer care in the Central New York region.
  • I am excited to join the team of Associated Medical Professionals of NY and look forward to helping patients in the community.”

Jackson Adds Protected Lifetime Income Benefit to RILA Suite

Retrieved on: 
понедельник, апреля 29, 2024
Personal Finance, Finance, Consulting, Professional Services, Insurance, Ecosystem, Risk, Literature, Retirement, Jackson National Life, Marketing, JXN, Life insurance

Jackson National Life Insurance Company ® (Jackson®), the main operating subsidiary of Jackson Financial Inc.1 (NYSE: JXN), today launched +Income, an add-on benefit available for an additional charge, offering guaranteed2 lifetime income3 through Jackson’s Market Link Pro® suite of registered index-linked annuities (RILAs).

Key Points: 
  • Jackson National Life Insurance Company ® (Jackson®), the main operating subsidiary of Jackson Financial Inc.1 (NYSE: JXN), today launched +Income, an add-on benefit available for an additional charge, offering guaranteed2 lifetime income3 through Jackson’s Market Link Pro® suite of registered index-linked annuities (RILAs).
  • +Income enables clients to create an immediate income stream or defer withdrawals, providing the opportunity to grow income over time.
  • To coincide with the launch of +Income, the tool now includes a new option to illustrate how lifetime income can impact client portfolios.
  • "Jackson has a strong track record of serving as a trusted provider of guaranteed lifetime income strategies for financial professionals and their clients,” continued Sward.

Cognito Therapeutics Announces Presentation at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2024 Meeting

Retrieved on: 
понедельник, апреля 29, 2024
Medical Devices, Health, Neurology, Research, Science, Biotechnology, Alzheimer's disease, Humanism, MCI, International Society, Literature, Patient, Caregiver, Cognito, Pharmacoeconomics, Therapy, Quality of life, Ageing, Pharmaceutical industry

Cognito Therapeutics , a leader in technology-based therapeutic interventions for neurodegenerative diseases, announced today a poster presentation at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2024 Meeting, held May 5-8 in Atlanta, GA.

Key Points: 
  • Cognito Therapeutics , a leader in technology-based therapeutic interventions for neurodegenerative diseases, announced today a poster presentation at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2024 Meeting, held May 5-8 in Atlanta, GA.
  • The presented research is a targeted literature review of the clinical, humanistic, and economic burden of Alzheimer’s Disease (AD).
  • This surge underscores the pressing need for improved understanding and management of this debilitating neurological disease, given the current limitations in treatment options.
  • A targeted literature review was conducted to gain insights into the clinical, humanistic, and economic burden of mild-to-moderate AD, including mild cognitive impairment (MCI).

New Pandemic Agreement: Pharma Wins, Developing World Loses, says AHF Global Public Health Institute

Retrieved on: 
пятница, апреля 26, 2024
COVID-19, Public Policy, Other Policy Issues, Healthcare Reform, Pharmaceutical, Social Activism, Communications, General Health, Philanthropy, Advocacy Group Opinion, Infectious Diseases, Government, Foundation, AIDS, Health, United Nations, Public, University, IHR, PABS, Language, WHO, Community of practice, Learning, Pandemic, World Health Organization, INB, Policy, Infection, Intergovernmental, Conference, Research, Vaccine, Hoarding, Literature, International Health Regulations, AIDS Healthcare Foundation, Panel, Global health, Secretariat, AHF, United Nations General Assembly, Lancet, Letter, Pharmaceutical industry

As the final Intergovernmental Negotiating Body (INB) meeting of the World Health Organization (WHO) Pandemic Agreement approaches, the AIDS Healthcare Foundation and the AHF Global Public Health Institute are voicing significant concerns about the April 16, 2024, Proposal for the WHO Pandemic Agreement.

Key Points: 
  • As the final Intergovernmental Negotiating Body (INB) meeting of the World Health Organization (WHO) Pandemic Agreement approaches, the AIDS Healthcare Foundation and the AHF Global Public Health Institute are voicing significant concerns about the April 16, 2024, Proposal for the WHO Pandemic Agreement.
  • In addition to the GPMB and the IPPPR, the Panel for a Global Public Health Convention and Spark Street Advisors have also emphasized the critical need for independent monitoring.
  • Empty handshakes in Geneva will not prevent another global health disaster, nor will it keep countries from trampling over each other when the next pandemic comes.
  • To learn more about the AHF Global Public Health Institute, visit https://ahfinstitute.org/ .

MoonLake Immunotherapeutics inks three-year technology partnership with Komodo Health to advance research on inflammatory skin and joint conditions 

Retrieved on: 
среда, апреля 10, 2024
Komodo, Psoriatic arthritis, Arthropathy, Holocene, HS, Skin, Hidradenitis suppurativa, Partnership, Research, Literature, Entrepreneurship, Disease, Steroid, Patient, Inflammation, Marketing, Moonlake, Prevalence, Pharmaceutical industry

San Francisco, US and Zug, Switzerland, April 10, 2024 – MoonLake Immunotherapeutics (“MoonLake”; Nasdaq: MLTX) a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, and Komodo Health today announce a new technology partnership to help improve treatment for people living with inflammatory skin and joint diseases.

Key Points: 
  • San Francisco, US and Zug, Switzerland, April 10, 2024 – MoonLake Immunotherapeutics (“MoonLake”; Nasdaq: MLTX) a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, and Komodo Health today announce a new technology partnership to help improve treatment for people living with inflammatory skin and joint diseases.
  • Through this multiyear technology partnership, MoonLake will utilize Komodo’s Healthcare Map and platform technologies to enable data-driven decision making across its clinical operations, medical, marketing, and market access teams.
  • Komodo’s data and technology applications will support MoonLake’s in-depth market research, clinical trial site selection, go-to-market strategies, and patient journey mapping – all aimed at accelerating the development of new treatment options and improving outcomes for patients with inflammatory skin and joint diseases.
  • Tino Anthamatten, VP Marketing & Market Access & Pricing, MoonLake Immunotherapeutics, commented: “We need an experienced technology partner that can help accelerate our disease insights for our clinical, medical, and commercial endeavors.

YC-Backed Yoneda Labs Raises $4 Million Seed Led by Khosla Ventures to Build Foundation Model for Chemists

Retrieved on: 
пятница, апреля 26, 2024
Science, Software, Biotechnology, Research, Pharmaceutical, Health, Artificial Intelligence, Technology, University, Machine learning, Khosla Ventures, YC, Literature, Automation, Chemistry, Robotics, University of California, Berkeley, Y Combinator, Drug development, Drug discovery, Running, Algorithm, UC, Pharmaceutical industry

Yoneda Labs , the Y Combinator startup building a foundation model for chemists working in drug discovery, today announced it has raised $4 million in seed capital from Khosla Ventures, 500 Emerging Europe, 468 Capital, Fellows Fund, and Y Combinator.

Key Points: 
  • Yoneda Labs , the Y Combinator startup building a foundation model for chemists working in drug discovery, today announced it has raised $4 million in seed capital from Khosla Ventures, 500 Emerging Europe, 468 Capital, Fellows Fund, and Y Combinator.
  • “At Yoneda, our vision is to build a foundation AI model that analyzes and predicts what will happen before a chemist has to run their experiment.
  • Yoneda Labs was founded by a group from the University of Cambridge with backgrounds in chemistry, robotics, and machine learning.
  • During their time at YC, the team identified 20,000 chemical reactions to generate proprietary data for their foundation model.

New Pandemic Agreement: Pharma Wins, Developing World Loses, says AHF Global Public Health Institute

Retrieved on: 
среда, апреля 24, 2024
COVID-19, Infectious Diseases, Public Policy, Government, AIDS, Health, Pharmaceutical, General Health, Other Policy Issues, United Nations, Public, University, IHR, PABS, Language, WHO, Community of practice, Learning, Pandemic, World Health Organization, INB, Policy, Infection, Intergovernmental, Conference, Research, Vaccine, Hoarding, Literature, International Health Regulations, AIDS Healthcare Foundation, Panel, Global health, Secretariat, AHF, United Nations General Assembly, Lancet, Letter, Pharmaceutical industry

As the final Intergovernmental Negotiating Body (INB) meeting of the World Health Organization (WHO) Pandemic Agreement approaches, the AIDS Healthcare Foundation and the AHF Global Public Health Institute are voicing significant concerns about the April 16, 2024 , Proposal for the WHO Pandemic Agreement.

Key Points: 
  • As the final Intergovernmental Negotiating Body (INB) meeting of the World Health Organization (WHO) Pandemic Agreement approaches, the AIDS Healthcare Foundation and the AHF Global Public Health Institute are voicing significant concerns about the April 16, 2024 , Proposal for the WHO Pandemic Agreement.
  • In addition to the GPMB and the IPPPR, the Panel for a Global Public Health Convention and Spark Street Advisors have also emphasized the critical need for independent monitoring.
  • Empty handshakes in Geneva will not prevent another global health disaster, nor will it keep countries from trampling over each other when the next pandemic comes.
  • To learn more about the AHF Global Public Health Institute, visit https://ahfinstitute.org/ .

National Volunteer Week: Storyteller Shares the Joy of Reading with Kentucky Families

Retrieved on: 
среда, апреля 24, 2024
Entertainment, Networks, Internet, Philanthropy, Family, Books, Consumer, Technology, Fund Raising, Foundation, Children, Other Philanthropy, Telecommunications, Education, Small business, National Volunteer Week, Book, Little League Baseball, Love, Literacy, Knights of Columbus, Parent, STEM, Literature, Kentucky Humanities Council, Knight, Student, Windstream Holdings, Caldecott, Organization

Campbell’s willingness to give back exemplifies the spirit of National Volunteer Week, which was established to celebrate Americans who dedicate themselves to bettering their communities.

Key Points: 
  • Campbell’s willingness to give back exemplifies the spirit of National Volunteer Week, which was established to celebrate Americans who dedicate themselves to bettering their communities.
  • Each week, a selected book (usually a Caldecott Winner), is read and then given to the families, allowing them to continue the experience at home.
  • “The funding for the program is provided by the Kentucky Humanities Council, with the Steel Reece Foundation as a dedicated sponsor.
  • His passion for promoting literacy and fostering a love for reading among Kentucky families has made a lasting impact on the community.

New Pandemic Agreement: Pharma Wins, Developing World Loses, says AHF Global Public Health Institute

Retrieved on: 
среда, апреля 24, 2024
Public Policy, Government, Pharmaceutical, AIDS, General Health, Health, Other Policy Issues, Infectious Diseases, Advocacy Group Opinion, United Nations, Public, University, IHR, PABS, Language, WHO, Community of practice, Learning, Pandemic, World Health Organization, INB, Policy, Infection, Intergovernmental, Conference, Research, Vaccine, Hoarding, Literature, International Health Regulations, AIDS Healthcare Foundation, Panel, Global health, Secretariat, AHF, United Nations General Assembly, Lancet, COVID-19, Letter, Pharmaceutical industry

As the final Intergovernmental Negotiating Body (INB) meeting of the World Health Organization (WHO) Pandemic Agreement approaches, the AIDS Healthcare Foundation and the AHF Global Public Health Institute are voicing significant concerns about the April 16, 2024, Proposal for the WHO Pandemic Agreement .

Key Points: 
  • As the final Intergovernmental Negotiating Body (INB) meeting of the World Health Organization (WHO) Pandemic Agreement approaches, the AIDS Healthcare Foundation and the AHF Global Public Health Institute are voicing significant concerns about the April 16, 2024, Proposal for the WHO Pandemic Agreement .
  • In addition to the GPMB and the IPPPR, the Panel for a Global Public Health Convention and Spark Street Advisors have also emphasized the critical need for independent monitoring.
  • Empty handshakes in Geneva will not prevent another global health disaster, nor will it keep countries from trampling over each other when the next pandemic comes.
  • To learn more about the AHF Global Public Health Institute, visit https://ahfinstitute.org/ .

PharmAlliance Announces Acquisition of CHEORS

Retrieved on: 
вторник, апреля 16, 2024
Science, Software, Other Science, Pharmaceutical, Health, Medical Devices, Data Management, Technology, MFH, RWE, HTA, Doctor of Philosophy, Literature, Patient, Acquisition, Multimedia, Biotechnology

With this addition, PharmAlliance strengthens its global reach and expands its launch and commercialization capabilities.

Key Points: 
  • With this addition, PharmAlliance strengthens its global reach and expands its launch and commercialization capabilities.
  • View the full release here: https://www.businesswire.com/news/home/20240416800738/en/
    CHEORS marks the third strategic acquisition for PharmAlliance, a portfolio company of Waud Capital Partners .
  • “CHEORS’ excellent reputation and unique approach is an important next step in the expansion of the PharmAlliance portfolio,” said Mark Bouck, Chairman & CEO of PharmAlliance and BioBridges.
  • "From the outset, the synergies between CHEORS and PharmAlliance have been very attractive.